Announced Tue, 7 Jul · 12:39 IST
Routine RTA certificate for Q1 FY27 demat confirmation
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.2%1-day move
₹1.90
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.2+0.0-5.3-1.1-2.1-5.3+2.1———
Up moveDown movePending
AI summary
Vivanza Biosciences submitted a routine compliance certificate from its Registrar and Transfer Agent, Purva Sharegistry, for the quarter ended 30 June 2026. Under SEBI Regulation 74(5), the RTA confirmed that share certificates received for dematerialisation were processed and the names of depositories substituted in the register of members within prescribed timelines. Only one shareholder, Anjana D Shah, dematerialised 50 shares during the quarter (in May 2026), and no dematerialisations occurred in June 2026.
Likely market impact
Routine regulatory compliance filing. No impact on operations, financials, or share price.